Oxeco PLC Stock London S.E.
Equities
OXE
GB00B1J5QT30
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- GBX | - |
03-19 | Tissue Regenix annual loss narrows sharply as revenue jumps | AN |
03-19 | Earnings Flash (TRX.L) TISSUE REGENIX GROUP Reports FY23 Revenue $29.5M | MT |
Sales 2024 * | 27.11M 34.52M 47.14M | Sales 2025 * | 31.03M 39.51M 53.97M | Capitalization | 43.66M 55.59M 75.92M |
---|---|---|---|---|---|
Net income 2024 * | - 0 0 | Net income 2025 * | - 0 0 | EV / Sales 2024 * | 1.71 x |
Net Debt 2024 * | 2.62M 3.34M 4.56M | Net Debt 2025 * | 3.84M 4.89M 6.68M | EV / Sales 2025 * | 1.53 x |
P/E ratio 2024 * |
-369
x | P/E ratio 2025 * |
148
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.25% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Lee
CEO | Chief Executive Officer | 63 | 18-12-31 |
Kirsten Lund
DFI | Director of Finance/CFO | - | 09-12-31 |
David Cocke
DFI | Director of Finance/CFO | 58 | 21-01-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Phillips
BRD | Director/Board Member | 63 | 21-01-04 |
George Phillips
BRD | Director/Board Member | 64 | 21-01-04 |
Daniel Lee
CEO | Chief Executive Officer | 63 | 18-12-31 |
1st Jan change | Capi. | |
---|---|---|
+19.82% | 7.85B | |
+31.59% | 4.28B | |
-30.43% | 2.64B | |
-15.20% | 1.47B | |
-26.60% | 1.3B | |
-34.43% | 1.14B | |
+10.41% | 987M | |
-35.57% | 901M | |
-22.74% | 696M |
- Stock Market
- Equities
- TRX Stock
- OXE Stock